One gene provides diagnoses for 30 patients whose condition was unexplained for years
“It was rewarding to be able to provide an explanation for their condition,” said Dr. Daniel Calame, first and corresponding author of the work.
Read More
Research
Recurrent meningiomas reveal insights into their aggressive behavior
The study opens new opportunities for future development of potential biomarkers and therapeutic agents for these challenging tumors.
Read More
Unexpected findings provide a deeper understanding of Myotonic Dystrophy Type 1
While the Baylor team was testing a strategy to improve heart defects associated with DM1, they uncovered an unexpected new insight into the condition.
Read More
ClinGen creates a robust, open-access platform to define the clinical relevance of genes and variants
ClinGen can be used to build evidence-based genetic testing panels, resolve discrepancies in variant classification and guide disclosure of genomic findings to patients.
Read More
Congratulations, Dr. Maria E. Bottazzi and Dr. Teresa A. Davis, Baylor’s newly elected members to the National Academy of Medicine!
Election to the National Academy of Medicine is considered one of the highest honors that recognizes individuals for their outstanding professional achievement and commitment to service in health and medicine.
Read More
A potentially simpler test and novel therapy for endometriosis
This is the first report of a unique metabolite profile linked to human endometriosis, bringing us closer to better ways to manage the condition.
Read More
Reviving immune responsiveness after tuberculosis
The findings could reduce the illness and mortality that occur after TB has been successfully treated.
Read More
DAPK3 emerges as a new regulator of migration of triple-negative breast cancer cells
The researchers’ next steps include studying how DAPK3 promotes TNBC migration and assess its potential value as a therapeutic target.
Read More
New mouse model mimics progression of Parkinson’s disease
This model can help identify new disease biomarkers and test therapies that could alter its progression, maybe even prevent the condition.
Read More
Center for NextGen Therapeutics helps match researchers to molecules
Dr. Jin Wang explains what the new Center for NextGen Therapeutics has to offer to researchers at Baylor College of Medicine, across the Texas Medical Center and beyond.
Read More